methylmalonic acid has been researched along with Cardiovascular Stroke in 3 studies
Methylmalonic Acid: A malonic acid derivative which is a vital intermediate in the metabolism of fat and protein. Abnormalities in methylmalonic acid metabolism lead to methylmalonic aciduria. This metabolic disease is attributed to a block in the enzymatic conversion of methylmalonyl CoA to succinyl CoA.
methylmalonic acid : A dicarboxylic acid that is malonic acid in which one of the methylene hydrogens is substituted by a methyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Elevated plasma methylmalonic acid (MMA) is reported in patients with established coronary heart disease (CHD) and is considered a marker of vitamin B12 deficiency." | 8.31 | Plasma methylmalonic acid predicts risk of acute myocardial infarction and mortality in patients with coronary heart disease: A prospective 2-cohort study. ( Berge, RK; Bjørnestad, EØ; Borsholm, R; Bønaa, KH; Dhar, I; Laupsa-Borge, J; Lysne, V; Mellgren, G; Nygård, OK; Olsen, T; Pedersen, ER; Svingen, GFT; Tell, GS; Ueland, PM; Ulvik, A, 2023) |
| "To evaluate whether low levels of holotranscobalamin (holoTC) or elevated levels of methylmalonic acid (MMA), both indicators of vitamin B(12) deficiency, might predispose to new cardiovascular events following an acute myocardial infarction (MI)." | 7.74 | Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction. ( Aarsetøy, H; Grundt, H; Mansoor, MA; Nilsen, DW; Reine, A; Valente, E, 2008) |
| "The level of total homocysteine (tHcy) that confers a risk of ischemic stroke is unsettled, and no prospective cohort studies have included sufficient elderly minority subjects." | 7.72 | Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study. ( Allen, R; Anand, K; Boden-Albala, B; Lee, HS; Paik, MC; Sacco, RL; Stabler, S, 2004) |
| "Elevated plasma methylmalonic acid (MMA) is reported in patients with established coronary heart disease (CHD) and is considered a marker of vitamin B12 deficiency." | 4.31 | Plasma methylmalonic acid predicts risk of acute myocardial infarction and mortality in patients with coronary heart disease: A prospective 2-cohort study. ( Berge, RK; Bjørnestad, EØ; Borsholm, R; Bønaa, KH; Dhar, I; Laupsa-Borge, J; Lysne, V; Mellgren, G; Nygård, OK; Olsen, T; Pedersen, ER; Svingen, GFT; Tell, GS; Ueland, PM; Ulvik, A, 2023) |
| "To evaluate whether low levels of holotranscobalamin (holoTC) or elevated levels of methylmalonic acid (MMA), both indicators of vitamin B(12) deficiency, might predispose to new cardiovascular events following an acute myocardial infarction (MI)." | 3.74 | Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction. ( Aarsetøy, H; Grundt, H; Mansoor, MA; Nilsen, DW; Reine, A; Valente, E, 2008) |
| "The level of total homocysteine (tHcy) that confers a risk of ischemic stroke is unsettled, and no prospective cohort studies have included sufficient elderly minority subjects." | 3.72 | Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study. ( Allen, R; Anand, K; Boden-Albala, B; Lee, HS; Paik, MC; Sacco, RL; Stabler, S, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dhar, I | 1 |
| Lysne, V | 1 |
| Ulvik, A | 1 |
| Svingen, GFT | 1 |
| Pedersen, ER | 1 |
| Bjørnestad, EØ | 1 |
| Olsen, T | 1 |
| Borsholm, R | 1 |
| Laupsa-Borge, J | 1 |
| Ueland, PM | 1 |
| Tell, GS | 1 |
| Berge, RK | 1 |
| Mellgren, G | 1 |
| Bønaa, KH | 1 |
| Nygård, OK | 1 |
| Sacco, RL | 1 |
| Anand, K | 1 |
| Lee, HS | 1 |
| Boden-Albala, B | 1 |
| Stabler, S | 1 |
| Allen, R | 1 |
| Paik, MC | 1 |
| Aarsetøy, H | 1 |
| Valente, E | 1 |
| Reine, A | 1 |
| Mansoor, MA | 1 |
| Grundt, H | 1 |
| Nilsen, DW | 1 |
3 other studies available for methylmalonic acid and Cardiovascular Stroke
| Article | Year |
|---|---|
Plasma methylmalonic acid predicts risk of acute myocardial infarction and mortality in patients with coronary heart disease: A prospective 2-cohort study.
Topics: Aged; Biomarkers; Cohort Studies; Coronary Disease; Female; Humans; Methylmalonic Acid; Myocardial I | 2023 |
Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study.
Topics: Aged; Black People; Cohort Studies; Female; Hispanic or Latino; Homocysteine; Humans; Male; Methylma | 2004 |
Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Female; Follow-Up Studies; Homocysteine; Humans; | 2008 |